For drugmakers, tailored medicine is both an opportunity and a (challenge) as sub-dividing tumors by their molecular type shrinks the market for individual therapies. Kidney cancer kills more than (100,000) people worldwide each year. Recent new drugs against the disease include Pfizer's Sutent and Bayer's Nexavar, which (block) cell proliferation and starve tumors of blood supply.
相关阅读:
医学英语口语课程
医学英语水平免费测试